VKH
BIVV

Virtu KCG Holdings’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Virtu KCG Holdings’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$407K Buy
+6,759
New +$385K 0.01% 1344

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Virtu KCG Holdings's BIVV Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q2 2017: 6,759 shares worth $407K. The stake represents 0.01% of the portfolio and ranks #1344 among its holdings.

452 funds tracked by Wall St. Rank hold BIVV as of Q2 2017.

  • Virtu KCG Holdings held 6,759 shares of Bioverativ Inc. Common Stock worth $407K as of Q2 2017.
  • Bioverativ Inc. Common Stock was a new Virtu KCG Holdings position in Q2 2017.
  • Bioverativ Inc. Common Stock made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1344 holding.
  • 452 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.